< Back to Schedule

Parallel Session: NAFLD and Non-Alcoholic Steatohepatitis- Clinical

Monday, November 16
9:00 am
10:30 am


No items found.

About the Session

Watch this live session to see some the top research in NAFLD and Non-Alcoholic Steatohepatitis. Content will only be aired on this date, at this time. Don't miss it!

  • Safety and Efficacy of Tropifexor in Patients with Fibrotic NonAlcoholic Steatohepatitis:48 Week Results from Part C of Phase 2 Flight-FXR Study
    Presenting Author Arun Sanyal
  • Characteristic Gene Expression Patterns in Whole Liver Tissue Associated with Distinct States of NAFLD
    Presenting Author Sonu Subudhi
  • Dietary Risks for Liver Related Mortality Among NonAlcoholic Fatty Liver Disease (NAFLD): Data From the Global Burden of Disease (GBD) 2017
    Presenting Author James M Paik
  • Treament with Growth Hormone Releasing Hormone Analog Reduces VEGFA, TGFβ1, and CSF1 Mechanisms of Tesamorelin Effect in NonAlcoholic Fatty Liver Disease
    Presenting Author Lindsay Fourman
  • Onset of Obesity-Related Pediatric Nonalcoholic Fatty Liver Disease (PNAFLD) During Prepubertal Growth Exacerbates Hepatic Inflammation and Mitochondrial DNA Depletion to Accelerate Liver Injury
    Presenting Author Preeti Viswanathan
  • HIV-Infected Persons with Hepatic Steatosis have a Unique Plasma Lipidome
    Presenting Author Curtis Gabriel